SCHEMBL21345694

SCHEMBL21345694

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccccc5)c5sc6c(-c7ccccc7)cc(-c7ccccc7)cc6c45)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.36
▸ KMT2A Q03164 5/20 0.36
▸ MAPT P10636 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ LIMK1 P53667 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ ADORA2A P29274 3/20 0.34
▸ ADORA1 P30542 3/20 0.34
▸ NTSR1 P30989 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ AXL P30530 4/20 0.33
▸ SGK1 O00141 2/20 0.33
▸ ATM Q13315 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ TNIK Q9UKE5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21345894 1.00 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22524014 1.00 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22524046 0.99 LIMK1 (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22524052 0.96 MEN1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22524051 0.96 LIMK1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21345696 0.96 LIMK1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21345733 0.96 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21345896 0.95 LIMK1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21345681 0.95 LIMK1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22524015 0.93 LIMK1 (0.35) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370782-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2022-06-28 — — US disclosed
US-20200317650-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2020-10-08 — — US disclosed
WO-2019172652-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2019-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11370782-B2 Compound and organic light emitting device comprising the same OXER1, ARL1, UBE2L3 MEN1 537/4885KMT2A 2693/4885MAPT 2622/4885
US-20200317650-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME OXER1, NR2E3, ORC3 MEN1 778/4885KMT2A 2977/4885MAPT 2713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback